โรงพยาบาลรามาธิบดี เป็นหน่วยงานหนึ่งในระดับภาควิชาของคณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล สังกัดกระทรวงการอุดมศึกษา วิทยาศาสตร์ วิจัยและนวัตกรรม และเป็นสถานพยาบาลแห่งหนึ่งของรัฐ ตั้งอยู่เลขที่ 270 ถนนพระราม 6 แขวงทุ่งพญาไท เขตราชเทวี กรุงเทพมหานคร 10400 มีเนื้อที่ทั้งหมด 38 ไร่ มีอาคารรวม 20 อาคาร ...

During the past decade, Ramathibodi Hospital conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 30 clinical trials were completed, i.e. on average, 32.6% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 17 clinical trials were completed. i.e. 41.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ramathibodi Hospital" #1 sponsor was "Mahidol University" with 26 trials, followed by "Ramathibodi Hospital" with 20 trials sponsored, "Gilead Sciences" with 11 trials sponsored, "Boehringer Ingelheim" with 9 trials sponsored and "Janssen Research & Development, LLC" with 9 trials sponsored. Other sponsors include 67 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ramathibodi Hospital" #1 collaborator was "Ramathibodi Hospital" with 4 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 110 trials.

According to Clinical.Site data, the most researched conditions in "Ramathibodi Hospital" are "HIV Infections" (13 trials), "HIV" (7 trials), "Atrial Fibrillation" (5 trials), "Acquired Immunodeficiency Syndrome" (2 trials) and "Atherosclerosis" (2 trials). Many other conditions were trialed in "Ramathibodi Hospital" in a lesser frequency.

Most popular intervention types in "Ramathibodi Hospital" are "Drug" (90 trials), "Other" (20 trials), "Device" (17 trials), "Procedure" (12 trials) and "Behavioral" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "ATV" (5 trials), "E/C/F/TAF" (5 trials), "FTC/TDF" (4 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ramathibodi Hospital" are 133 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 41 active trials in "Ramathibodi Hospital". 1 are not yet recruiting, 23 are recruiting, 15 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 79 completed trials in Ramathibodi Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Ramathibodi Hospital, 6 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 39 trials that are defined as “Not Applicable".